Symbol="GNFT"
AssetType="Common Stock"
Name="Genfit"
Description="Genfit SA, a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company is headquartered in Loos, France."
CIK="1757064"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="PARC EURASANTE, 885, AVENUE EUGENE AVINEE, LOOS, FR"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="210433000"
EBITDA="-25884000"
PERatio="None"
PEGRatio="None"
BookValue="1.902"
DividendPerShare="0"
DividendYield="0"
EPS="-0.52"
RevenuePerShareTTM="0.528"
ProfitMargin="-0.904"
OperatingMarginTTM="-1.053"
ReturnOnAssetsTTM="-0.0695"
ReturnOnEquityTTM="-0.222"
RevenueTTM="26246000"
GrossProfitTTM="26246000"
DilutedEPSTTM="-0.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.828"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.913"
PriceToBookRatio="1.576"
EVToRevenue="0.362"
EVToEBITDA="0.541"
Beta="0.889"
num_52WeekHigh="5.05"
num_52WeekLow="3.29"
num_50DayMovingAverage="4.155"
num_200DayMovingAverage="4.081"
SharesOutstanding="49835000"
DividendDate="None"
ExDividendDate="None"
symbol="GNFT"
open="3.94"
high="3.98"
low="3.84"
price="3.92"
volume="17573.00"
latest_trading_day="2023-07-21"
previous_close="3.83"
change="0.09"
change_percent="2.3499%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="57"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="67996"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="1098"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="683"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_positive_thumbnail_id_2="687"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
